Goehring & Rozencwajg Associates LLC Decreases Position in Nutrien Ltd. (NYSE:NTR)

Goehring & Rozencwajg Associates LLC decreased its position in Nutrien Ltd. (NYSE:NTR) by 5.6% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 200,439 shares of the company’s stock after selling 11,858 shares during the period. Nutrien comprises approximately 1.8% of Goehring & Rozencwajg Associates LLC’s portfolio, making the stock its 22nd biggest holding. Goehring & Rozencwajg Associates LLC’s holdings in Nutrien were worth $9,004,000 at the end of the most recent quarter.

Other hedge funds have also made changes to their positions in the company. Goodman Financial Corp grew its stake in Nutrien by 4.6% in the 3rd quarter. Goodman Financial Corp now owns 253,860 shares of the company’s stock valued at $12,201,000 after acquiring an additional 11,058 shares during the last quarter. CORDA Investment Management LLC. lifted its holdings in shares of Nutrien by 7.0% in the third quarter. CORDA Investment Management LLC. now owns 494,745 shares of the company’s stock valued at $23,777,000 after purchasing an additional 32,541 shares in the last quarter. Charles Schwab Investment Management Inc. grew its position in shares of Nutrien by 10.0% in the third quarter. Charles Schwab Investment Management Inc. now owns 1,742,351 shares of the company’s stock valued at $83,812,000 after purchasing an additional 157,932 shares during the last quarter. Cardinal Capital Management Inc. increased its stake in shares of Nutrien by 4.3% during the 3rd quarter. Cardinal Capital Management Inc. now owns 564,078 shares of the company’s stock worth $27,139,000 after purchasing an additional 23,117 shares in the last quarter. Finally, Stephens Inc. AR raised its position in shares of Nutrien by 335.0% during the 3rd quarter. Stephens Inc. AR now owns 70,301 shares of the company’s stock worth $3,379,000 after purchasing an additional 54,138 shares during the last quarter. Hedge funds and other institutional investors own 63.10% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts have commented on NTR shares. Raymond James upgraded Nutrien from a “market perform” rating to an “outperform” rating and increased their target price for the company from $58.00 to $60.00 in a report on Tuesday, December 3rd. Oppenheimer started coverage on Nutrien in a research note on Thursday, December 12th. They set an “outperform” rating and a $60.00 price objective on the stock. Piper Sandler boosted their target price on shares of Nutrien from $58.00 to $63.00 and gave the company an “overweight” rating in a research note on Monday, January 27th. TD Securities decreased their price target on shares of Nutrien from $63.00 to $61.00 and set a “buy” rating on the stock in a research note on Tuesday, November 12th. Finally, JPMorgan Chase & Co. raised shares of Nutrien from an “underweight” rating to a “neutral” rating and boosted their price objective for the company from $40.00 to $50.00 in a research report on Monday, January 13th. One analyst has rated the stock with a sell rating, six have given a hold rating and ten have issued a buy rating to the company. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $58.94.

Nutrien Trading Down 0.4 %

Shares of NTR opened at $50.32 on Friday. Nutrien Ltd. has a twelve month low of $43.69 and a twelve month high of $60.87. The firm has a market capitalization of $24.71 billion, a P/E ratio of 33.77, a price-to-earnings-growth ratio of 1.13 and a beta of 0.81. The company has a current ratio of 1.27, a quick ratio of 0.82 and a debt-to-equity ratio of 0.38. The stock’s fifty day simple moving average is $48.66 and its 200 day simple moving average is $48.11.

Nutrien (NYSE:NTR) last announced its quarterly earnings results on Wednesday, November 6th. The company reported $0.39 EPS for the quarter, missing the consensus estimate of $0.43 by ($0.04). The firm had revenue of $5.35 billion for the quarter, compared to analyst estimates of $5.26 billion. Nutrien had a return on equity of 6.99% and a net margin of 2.79%. The business’s revenue was down 5.0% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.35 earnings per share. On average, equities research analysts forecast that Nutrien Ltd. will post 3.49 earnings per share for the current year.

Nutrien Profile

Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.